top of page

English News Releases

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

2021年7月13日

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

2021年7月9日

HekaBio Completes Financing Round Jan. 29, 2021

HekaBio Completes Financing Round Jan. 29, 2021

HekaBio Completes Financing Round Jan. 29, 2021

2021年1月29日

Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio Sept. 23, 2020

Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio Sept. 23, 2020

Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio Sept. 23, 2020

2020年9月23日

HekaBio raised 552 million yen in their 2nd issuance of new shares (Series A Phase1) Dec. 7, 2018

HekaBio raised 552 million yen in their 2nd issuance of new shares (Series A Phase1) Dec. 7, 2018

HekaBio raised 552 million yen in their 2nd issuance of new shares (Series A Phase1) Dec. 7, 2018

2018年12月7日

Alpha Tau Medical presented clinical results of its alpha radiation cancer treatment at ASTRO Nov. 9, 2018

Alpha Tau Medical presented clinical results of its alpha radiation cancer treatment at ASTRO Nov. 9, 2018

Alpha Tau Medical presented clinical results of its alpha radiation cancer treatment at ASTRO Nov. 9, 2018

2018年11月9日

トップページへ

bottom of page